Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You and Your Team.

Learn More →

Immunotherapy 2.0: Improving the Response to Checkpoint Inhibitors

Immunotherapy 2.0: Improving the Response to Checkpoint Inhibitors This Medical News article discusses the evolution of checkpoint inhibitor immunotherapies to improve efficacy and predict which patients will benefit the most. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA American Medical Association

Immunotherapy 2.0: Improving the Response to Checkpoint Inhibitors

JAMA , Volume 321 (2) – Jan 15, 2019

Loading next page...
 
/lp/american-medical-association/immunotherapy-2-0-improving-the-response-to-checkpoint-inhibitors-ZCucB0x8vN
Publisher
American Medical Association
Copyright
Copyright 2018 American Medical Association. All Rights Reserved.
ISSN
0098-7484
eISSN
1538-3598
DOI
10.1001/jama.2018.18306
Publisher site
See Article on Publisher Site

Abstract

This Medical News article discusses the evolution of checkpoint inhibitor immunotherapies to improve efficacy and predict which patients will benefit the most.

Journal

JAMAAmerican Medical Association

Published: Jan 15, 2019

There are no references for this article.